1CP
ZBH icon

1015 Capital Partners’s Zimmer Biomet ZBH Stock Holding History

1015 Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689 Hold
8
– – ﹤0.01% 519
2026
Q1 		$723 Sell
8
-10
-56% -$918 ﹤0.01% 483
2025
Q4 		$1.62K Buy
+18
New +$1.71K ﹤0.01% 343

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

1015 Capital Partners's ZBH Position: Q2 2026 in Review

1015 Capital Partners held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 8 shares worth $689. The position accounts for ﹤0.01% of the portfolio, ranked #519.

1015 Capital Partners first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.62K in Q4 2025. 902 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • 1015 Capital Partners held 8 shares of Zimmer Biomet worth $689 as of Q2 2026.
  • 1015 Capital Partners left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of 1015 Capital Partners's portfolio in Q2 2026, its #519 holding.
  • 1015 Capital Partners first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • 1015 Capital Partners's Zimmer Biomet position peaked at $1.62K in Q4 2025.
  • 902 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.